Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159556 · ClinicalTrials.gov registry record · NA
Effects of Peanuts on Immunity and Cardiometabolic Risk Factors
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT06159556 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 80 participants.
The verdict
NCT06159556, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.
Interventions
- OTHER Peanut intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06159556
The ClinicalTrials.gov registry entry for NCT06159556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut intake is the first listed.
NCT06159556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06159556 about?
NCT06159556 is a clinical study titled "Effects of Peanuts on Immunity and Cardiometabolic Risk Factors". The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.
What is the current status of trial NCT06159556?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2024-01-31. Estimated completion is 2024-09-26.
What interventions are being tested in trial NCT06159556?
The interventions under investigation include: Peanut intake (OTHER).
Who is sponsoring clinical trial NCT06159556?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.